Aer Therapeutics, Inc. — Form D
Aer Therapeutics, Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-22. The offering totals $36.9M, of which $15.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-22
- Form: D
- Accession: 0001959576-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $36.9M
- Amount sold: $15.9M
- Remaining: $21.0M
- Investors: 23
- Date of first sale: 2022-12-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-468459
Issuer
- Name: Aer Therapeutics, Inc.
- CIK: 0001959576
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 400 W NORTH STREET, RALEIGH, NC, 27603
- Phone: 213-247-8328
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| James Shaffer | Director | Raleigh, NC |
| James Shaffer | Executive Officer | Raleigh, NC |
| Rishi Gupta | Director | New York, NY |
| Christy Shaffer | Director | Durham, NC |
| Tim Shannon | Director | Westport, CT |
| THOMAS MATHERS | Director | RALEIGH, NC |
| THOMAS MATHERS | Executive Officer | RALEIGH, NC |
| JOHN FAHY | Director | RALEIGH, NC |
Other filings by this issuer (1)
More